Relapse of acute myelogenous leukemia during low dose interleukin-2 (IL-2) therapy. Phenotypic evolution associated with strong expression of the IL-2 receptor alpha chain.

Source:http://linkedlifedata.com/resource/pubmed/id/8826915

Cancer 1995 Apr 1 75 7 1594-7

Download in:

View as

General Info

PMID
8826915